Sapient Capital LLC Sells 500 Shares of CVS Health Co. (NYSE:CVS)

Sapient Capital LLC reduced its stake in CVS Health Co. (NYSE:CVS) by 2.9% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 16,896 shares of the pharmacy operator’s stock after selling 500 shares during the quarter. Sapient Capital LLC’s holdings in CVS Health were worth $998,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. USA Financial Formulas lifted its holdings in shares of CVS Health by 573.2% during the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 321 shares during the period. Ables Iannone Moore & Associates Inc. bought a new position in CVS Health in the 4th quarter worth about $32,000. Creekmur Asset Management LLC bought a new stake in shares of CVS Health during the fourth quarter valued at approximately $34,000. Steph & Co. grew its holdings in CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares in the last quarter. Finally, Kapitalo Investimentos Ltda acquired a new position in shares of CVS Health during the fourth quarter valued at $36,000. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of research analyst reports. Mizuho cut their target price on CVS Health from $86.00 to $72.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Bank of America reduced their price objective on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Robert W. Baird began coverage on shares of CVS Health in a research note on Thursday, May 30th. They set a “neutral” rating and a $61.00 target price for the company. Baird R W upgraded shares of CVS Health to a “hold” rating in a research report on Thursday, May 30th. Finally, Leerink Partnrs downgraded CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 1st. Twelve analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $73.24.

CVS Health Stock Down 2.3 %

CVS traded down $1.33 during trading on Monday, reaching $55.78. 4,323,549 shares of the stock traded hands, compared to its average volume of 11,499,998. The stock has a market cap of $70.02 billion, a price-to-earnings ratio of 9.92, a price-to-earnings-growth ratio of 0.57 and a beta of 0.52. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The stock’s 50-day simple moving average is $59.45 and its two-hundred day simple moving average is $66.14.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. The firm had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter last year, the firm earned $2.21 earnings per share. As a group, equities research analysts expect that CVS Health Co. will post 7 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.77%. The ex-dividend date of this dividend was Monday, July 22nd. CVS Health’s payout ratio is 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.